Categories: All postsCannabis

Flower One Holdings has a 117 per cent upside, says Mackie Research

US cannabis company Flower One Holdings (Flower One Holdings Stock Quote, Chart CSE:FONE) just got a target raise from Mackie Research’s Greg McLeish, who, after touring facilities, says the company’s Nevada build-out is progressing smoothly.

Vertically-integrated cannabis company Flower One has now completed conversion of its commercial greenhouse in North Las Vegas, making it capable of producing more than 62,500 kg of dried flower per year, by far the largest cannabis cultivation operation in the state.

In a client update Thursday, McLeish says Nevada’s climate, with its 290 days of sunlight per year and more than ten hours of sunlight per day, plus its dry heat and low humidity, is ideal for growing cannabis in a greenhouse environment.

A dollar per gram for Flower One Holdings

The analyst says the scale of FONE’s operations should result in an all-in cash cost per gram of less than $1.00, which he says compares very favourably to competitors that operate smaller-scale greenhouses and indoor operations. Once Flower One reaches scale, McLeish says that it should be generating EBITDA margins above 30 per cent. (All figures in US dollars unless noted otherwise.)

“We had been applying a 10x EV/EBITDA multiple to value Flower One to take into account the execution risk associated with building out a successful large scale greenhouse operation. However, this execution risk has been mitigated as evidenced by our recent tour of the NLV Greenhouse. Additionally, the closing of the C$57.5 million convertible debenture financing and the recently announced licensing agreements and brand partnerships will help to underpin our financial forecasts through 2020. As a result, we are increasing our EV/EBITDA target multiple to 11x from 10x,” says McLeish.

The analyst is calling for fiscal 2019 revenue and EBITDA of $134.9 million and $45.1 million, respectively, and fiscal 2020 revenue and EBITDA of $251.1 million and $90.6 million, respectively. McLeish is maintaining his “Buy” rating and moving his target price from C$5.50 to C$6.50, which represented a projected return of 117 per cent at the time of publication.

Flower One Holdings Company Profile via Mackie Research Capital

Flower One Holdings Inc. is a vertically integrated cannabis company that is targeting the medical and recreational cannabis markets in the state of Nevada. The company is currently in the process of retrofitting its 455,000 ft² “NLV Greenhouse” into a cannabis cultivation and production facility. The conversion of the greenhouse is now complete and once the facility is fully operational, it will be capable of producing more than 140,000 pounds (62,500 kilograms) of dry flower per year.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: fone
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

7 hours ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

17 hours ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

19 hours ago

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

1 day ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

2 days ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

2 days ago